文献速递儿科与产科急症消化、代谢与肾脏急症

昂丹司琼处方与儿童胃肠炎急诊72小时复诊率降低相关

Ondansetron Prescription Is Associated With Reduced Return Visits to the Pediatric Emergency Department for Children With Gastroenteritis.
PubMed 文献 · Ann Emerg Med · 2020-05-26
一句话结论儿童呕吐或胃肠炎离院时开具昂丹司琼处方与72小时急诊复诊 odds 降低相关(aOR 0.84),且未增加阑尾炎等替代诊断漏诊。

这项回顾性队列研究纳入2012至2017年因胃肠炎、胃炎、呕吐或呕吐伴腹泻就诊于儿科急诊或附属紧急护理中心的6月龄至18岁患者共82139例,中位年龄4岁,出院时13.4%获昂丹司琼处方。72小时复诊率为4.7%。多因素logistic回归显示,获昂丹司琼处方者72小时复诊 odds 降低(aOR 0.84,95%CI 0.75-0.93),胃肠炎亚组同样降低(aOR 0.82,95%CI 0.72-0.95)。复诊时阑尾炎诊断两组无显著差异(OR 0.97,95%CI 0.37-2.18)。作者结论认为昂丹司琼处方与72小时急诊复诊率降低相关,且不增加替代诊断被掩盖的风险。

要点

  • 儿童呕吐或胃肠炎离院时开具昂丹司琼处方与72小时急诊复诊 odds 降低相关(aOR 0.84,95%CI 0.75-0.93)。
  • 明确诊断胃肠炎的亚组中,昂丹司琼处方与72小时复诊 odds 降低相关(aOR 0.82,95%CI 0.72-0.95)。
  • 复诊时阑尾炎诊断在获处方组与未获处方组间无显著差异(OR 0.97,95%CI 0.37-2.18)。
  • 研究共纳入82139例6月龄至18岁患儿,出院时13.4%获昂丹司琼处方,72小时复诊率4.7%。

适用人群与场景

  • 6月龄至18岁、因呕吐或胃肠炎就诊于儿科急诊或其附属紧急护理中心的患儿。
  • 纳入诊断包括胃肠炎、胃炎、呕吐、呕吐伴腹泻(ICD-9或ICD-10诊断)。

研究设计与关键结果

  • 研究类型为回顾性队列研究,纳入2012至2017年6月龄至18岁患儿共82139例,中位年龄4岁。
  • 出院时13.4%患儿获昂丹司琼处方,72小时复诊率为4.7%。
  • 获昂丹司琼处方者72小时复诊 odds 降低(aOR 0.84,95%CI 0.75-0.93)。
  • 胃肠炎亚组获处方者72小时复诊 odds 降低(aOR 0.82,95%CI 0.72-0.95)。
  • 复诊时阑尾炎诊断两组无显著差异(OR 0.97,95%CI 0.37-2.18)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,对呕吐或急性胃肠炎的儿童开具昂丹司琼处方与72小时急诊复诊率降低相关,且不增加替代诊断被掩盖的风险。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: We determine whether an ondansetron prescription for pediatric patients with vomiting or gastroenteritis is associated with decreased return visits to the emergency department (ED), and whether alternate diagnoses are more frequent on return visits in patients prescribed ondansetron.

METHODS: This is a retrospective cohort study of patients 6 months to 18 years of age, presenting to a pediatric ED or its affiliated urgent care centers between 2012 and 2017 with an International Classification of Diseases, Ninth Revision or International Statistical Classification of Diseases and Related Health Problems, 10th Revision diagnosis of gastroenteritis, gastritis, vomiting, or vomiting with diarrhea. Multivariate logistic regression analysis was used to measure the association between an ondansetron prescription and the odds of 72-hour return visits. Rates of alternate diagnoses on return visits (appendicitis, intussusception, intracranial mass, meningitis, and diabetic ketoacidosis) were compared between patients who were prescribed ondansetron for home use and those who were not.

RESULTS: A total of 82,139 patients were studied, with a median age of 4 years. An ondansetron prescription was given to 13.4% of patients on discharge. The 72-hour return visit rate was 4.7%. Patients receiving an ondansetron prescription had decreased odds of 72-hour return visits (adjusted odds ratio 0.84; 95% confidence interval 0.75 to 0.93). The subgroup of patients specifically receiving a diagnosis of gastroenteritis had decreased odds of 72-hour return visits (adjusted odds ratio 0.82; 95% confidence interval 0.72 to 0.95). There was no significant difference between groups in the diagnosis of appendicitis on return visit (odds ratio 0.97; 95% confidence interval 0.37 to 2.18).

CONCLUSION: An ondansetron prescription is associated with reduced 72-hour ED return visit rates for children with vomiting or acute gastroenteritis and is not associated with masking alternate diagnoses.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Benary D, Lozano JM, Higley R, et al. Ondansetron Prescription Is Associated With Reduced Return Visits to the Pediatric Emergency Department for Children With Gastroenteritis. Ann Emerg Med. 2020. PMID: 32471647. doi:10.1016/j.annemergmed.2020.04.012

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。